Timolumab 产品活性：Timolumab (BTT1023 ) 是一种重组的、全人的单克隆，可特异性结合VAP-1。Timolumab (BTT1023 ) 可用于慢性炎症性疾病的研究。 产品来源： https://www.medchemexpress.cn/timolumab.html 研究领域：Immunology/Inflammation 作用靶点：AP-1 In Vitro: Timolumab (BTT1023 ) binds to human VAP-1, thereby blocking its function as an adhesion molecule. It also recognizes VAP-1 of other primates and rabbits but does not cross-react with rat or mouse. Timolumab (BTT1023 ) is potentially useful for the treatment and in vivo imaging of inflammatory conditions such as rheumatoid arthritis. 相关产品：T-5224 | SR 11302 | E3330 | Berberine sulfate | INI-43 | Fargesin | IMM-H007 | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid | Ganoderic acid H | (+)-Glaucarubinone | Chloranthalactone B | Glucocorticoid receptor modulator 1 | DL-Syringaresinol | Fas C-Terminal Tripeptide | Methyllinderone | SPC 839 | SSAO/VAP-1 inhibitor 1 | Vapaliximab 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。